World's Best Scientists 2026 revealed!
EJNMMI Radiopharmacy and Chemistry
H-index 14

EJNMMI Radiopharmacy and Chemistry

2365-421X

Published by: Springer

https://ejnmmipharmchem.springeropen.com/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 664 24 40 11

Additional Metrics

Number of Best Scientists*: 76
Documents by Best Scientists*: 77
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 32
SCIMAGO SJR: 0.888
Impact Factor: 3.3

Overview

Top Research Topics at EJNMMI Radiopharmacy and Chemistry?

Radiochemistry, Radiosynthesis, Yield (chemistry), Biodistribution and Chromatography are among the topics commonly tackled in EJNMMI Radiopharmacy and Chemistry. The journal explores issues in Radiochemistry which can be linked to other research areas like Extraction (chemistry), Automated radiosynthesis, Chelation, Radionuclide therapy and Irradiation. EJNMMI Radiopharmacy and Chemistry tackles research works in Radiosynthesis as well as Fully automated.

The Yield (chemistry) works featured in it incorporate elements from Elution and Nuclear chemistry. The studies on Biodistribution discussed can also contribute to research in the domains of Ex vivo, Cancer research, Positron emission tomography and DOTA. It blends together research topics in Cancer research and Molecular medicine.

The majority of Positron emission tomography studies presented zero in on Pet imaging. It aims to bridge the gap between the study of DOTA and Bifunctional. Aside from discussions in In vitro, the journal also deals with the subject of Peptide which intersects with Ligand disciplines.

  • Radiochemistry (24.83%)
  • Radiosynthesis (15.86%)
  • Yield (chemistry) (15.86%)

What are the most cited papers published in the journal?

  • Auger electrons for cancer therapy – a review (67 citations)
  • Targeting of activated fibroblasts for imaging and therapy. (43 citations)
  • Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics (42 citations)

Research areas of the most cited articles at EJNMMI Radiopharmacy and Chemistry:

The most cited papers investigate areas of study like Pet imaging, Nuclear medicine, DOTA, Cancer research and Biomedical engineering. The published articles connects the study in DOTA with the closely related areas of Biodistribution. While Cancer research is the focus of the most cited publications, it also provides insights into the studies of Cancer cell, Cancer and Growth inhibition.

What topics the last edition of the journal is best known for?

  • Organic chemistry
  • Enzyme
  • Internal medicine

The previous edition focused in particular on these issues:

Radiochemistry, Radiosynthesis, Yield (chemistry), Fully automated and Peptide are the subjects of interest in EJNMMI Radiopharmacy and Chemistry. Some problems in Radiochemistry that were presented in it overlapped with concepts under Biomolecule and 18f fluoride. The research on Radiosynthesis featured in the journal combines topics in other fields like Bioinformatics, High-performance liquid chromatography, Combinatorial chemistry, Pet imaging and Nucleophilic substitution.

The concepts on Yield (chemistry) presented in EJNMMI Radiopharmacy and Chemistry can also apply to other research fields, including Chromatography, Elution and Aqueous solution. Some problems in Peptide that were presented in the journal overlapped with concepts under Molecular biology, In vitro and Ligand. EJNMMI Radiopharmacy and Chemistry explores research in Positron emission tomography and overlapping concepts in Cancer research to expand the discourse in Biodistribution.

The most cited articles from the last journal are:

  • Multi-Curie Production of Gallium-68 on a Biomedical Cyclotron and Automated Radiolabelling of PSMA-11 and DOTATATE (9 citations)
  • Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors? (6 citations)
  • Fully-automated synthesis of 177 Lu labelled FAPI derivatives on the module modular lab-Eazy (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in EJNMMI Radiopharmacy and Chemistry (based on the number of publications) are:

  • Philip H. Elsinga (14 papers) published 5 papers at the last edition, 4 more than at the previous edition,
  • Clemens Decristoforo (10 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Martin Béhé (9 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Roger Schibli (8 papers) absent at the last edition,
  • Marianne Patt (8 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in EJNMMI Radiopharmacy and Chemistry (based on the number of publications) are:

  • Paul Scherrer Institute (13 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University Medical Center Groningen (13 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • Katholieke Universiteit Leuven (8 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University of Michigan (8 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Helmholtz-Zentrum Dresden-Rossendorf (8 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.89% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 35.48% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.45% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 45.16% of all publications and 12.90% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.

    Euy Sung Moon;Filipe Elvas;Gwendolyn Vliegen;Stef De Lombaerde

    (2020)
    77 Citations
  • EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality

    Gert Luurtsema;Verena Pichler;Salvatore Bongarzone;Yann Seimbille

    (2021)
    50 Citations
  • Closing the gap between 19F and 18F chemistry

    Javier Ajenjo;Gianluca Destro;Bart Cornelissen;Véronique Gouverneur

    (2021)
    46 Citations
  • Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging.

    C. Favaretto;C. Favaretto;Z. Talip;F. Borgna;P. V. Grundler

    (2021)
    34 Citations
  • A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals

    (2021)
    32 Citations
  • 68 Ga, 44 Sc and 177 Lu-labeled AAZTA 5 -PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues

    Jean-Philippe Sinnes;Ulrike Bauder-Wüst;Martin Schäfer;Euy Sung Moon

    (2020)
    20 Citations
  • Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)

    Isaac M. Jackson;Isaac M. Jackson;So Jeong Lee;So Jeong Lee;Alexandra R. Sowa;Melissa E. Rodnick

    (2020)
    19 Citations
  • Advances in the automated synthesis of 6-[ 18 F]Fluoro-L-DOPA

    Ângela C. B. Neves;Ivanna Hrynchak;Inês Fonseca;Vítor H. P. Alves

    (2021)
    17 Citations
  • Multi-patient dose synthesis of [18F]Flumazenil via a copper-mediated 18F-fluorination

    (2022)
    16 Citations
  • Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu

    Sadaf Aghevlian;Zhongli Cai;David Hedley;Mitchell A. Winnik

    (2020)
    14 Citations

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various advanced online degrees and career pathways in healthcare and pharmaceuticals. For those interested in clinical practice and leadership roles, exploring the best dnp programs can be a valuable step. These programs, often designed without clinical requirements, offer flexibility for working professionals aiming to advance in nursing leadership and clinical practice.

Chemistry graduates eyeing pharmaceutical careers might consider an online doctor of pharmacy program. Such programs equip students with the expertise needed for roles in drug development, regulation, and patient care, all while accommodating busy schedules.

For registered nurses wanting to enhance their qualifications, the easiest rn to bsn online program options provide accessible pathways to a Bachelor of Science in Nursing, which can accelerate career growth and specialization.

Additionally, accelerated pharmacy pathways are available for those seeking a faster route to becoming licensed pharmacists. The accelerated pharmacy programs are designed to reduce the time spent in school while maintaining rigorous training standards.

Best Scientists Contributing to This Journal

Recently Published Articles